Annual Report 2025
Auditor’s opinion: a true and fair view. Read auditor’s report (PDF p. 44)
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group / as at 2025-12-31 | 2024Group / as at 2024-12-31 | Source |
|---|---|---|---|
| Non-current assets | |||
| Property, plant and equipmentSingapore dollars thousands | 5,040 | 4,262 | PDF p. 47 |
| Intangible assetsSingapore dollars thousands | 240 | 213 | PDF p. 47 |
| Investment in subsidiariesSingapore dollars thousands | − | − | PDF p. 47 |
| Deferred tax assetsSingapore dollars thousands | 2,050 | 1,598 | PDF p. 47 |
| Total non-current assets (unlabelled in source)Singapore dollars thousands | 7,330 | 6,073 | PDF p. 47 |
| Current assets | |||
| InventoriesSingapore dollars thousands | 98 | 84 | PDF p. 47 |
| Trade and other receivablesSingapore dollars thousands | 9,220 | 3,796 | PDF p. 47 |
| Cash and cash equivalentsSingapore dollars thousands | 67,284 | 29,715 | PDF p. 47 |
| Total current assets (unlabelled in source)Singapore dollars thousands | 76,602 | 33,595 | PDF p. 47 |
| Total assetsSingapore dollars thousands | 83,932 | 39,668 | PDF p. 47 |
| Equity | |||
| Share capitalSingapore dollars thousands | 27,360 | 100 | PDF p. 47 |
| Retained earningsSingapore dollars thousands | 12,518 | 3,997 | PDF p. 47 |
| Translation reserveSingapore dollars thousands | 8 | (115) | PDF p. 47 |
| Equity attributable to the owners of the CompanySingapore dollars thousands | 39,886 | 3,982 | PDF p. 47 |
| Non-current liabilities | |||
| Contract liabilitiesSingapore dollars thousands | 2,455 | 2,107 | PDF p. 47 |
| Lease liabilitiesSingapore dollars thousands | 2,808 | 2,422 | PDF p. 47 |
| Provision for reinstatement costsSingapore dollars thousands | 184 | 127 | PDF p. 47 |
| Deferred tax liabilitiesSingapore dollars thousands | 121 | 17 | PDF p. 47 |
| Total non-current liabilities (unlabelled in source)Singapore dollars thousands | 5,568 | 4,673 | PDF p. 47 |
| Current liabilities | |||
| Trade and other payablesSingapore dollars thousands | 7,443 | 4,083 | PDF p. 47 |
| Contract liabilitiesSingapore dollars thousands | 26,512 | 23,458 | PDF p. 47 |
| Lease liabilitiesSingapore dollars thousands | 1,185 | 1,120 | PDF p. 47 |
| Current tax liabilitiesSingapore dollars thousands | 3,338 | 2,352 | PDF p. 47 |
| Total current liabilities (unlabelled in source)Singapore dollars thousands | 38,478 | 31,013 | PDF p. 47 |
| Total liabilitiesSingapore dollars thousands | 44,046 | 35,686 | PDF p. 47 |
| Total equity and liabilitiesSingapore dollars thousands | 83,932 | 39,668 | PDF p. 47 |
Original report: PDF p. 47 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Company / as at 2025-12-31 | 2024Company / as at 2024-12-31 | Source |
|---|---|---|---|
| Non-current assets | |||
| Property, plant and equipmentSingapore dollars thousands | 2,257 | 1,291 | PDF p. 47 |
| Intangible assetsSingapore dollars thousands | 184 | 53 | PDF p. 47 |
| Investment in subsidiariesSingapore dollars thousands | 197 | 197 | PDF p. 47 |
| Deferred tax assetsSingapore dollars thousands | − | − | PDF p. 47 |
| Total non-current assets (unlabelled in source)Singapore dollars thousands | 2,638 | 1,541 | PDF p. 47 |
| Current assets | |||
| InventoriesSingapore dollars thousands | 35 | 31 | PDF p. 47 |
| Trade and other receivablesSingapore dollars thousands | 15,961 | 10,534 | PDF p. 47 |
| Cash and cash equivalentsSingapore dollars thousands | 53,531 | 18,989 | PDF p. 47 |
| Total current assets (unlabelled in source)Singapore dollars thousands | 69,527 | 29,554 | PDF p. 47 |
| Total assetsSingapore dollars thousands | 72,165 | 31,095 | PDF p. 47 |
| Equity | |||
| Share capitalSingapore dollars thousands | 27,360 | 100 | PDF p. 47 |
| Retained earningsSingapore dollars thousands | 15,726 | 8,194 | PDF p. 47 |
| Translation reserveSingapore dollars thousands | − | − | PDF p. 47 |
| Equity attributable to the owners of the CompanySingapore dollars thousands | 43,086 | 8,294 | PDF p. 47 |
| Non-current liabilities | |||
| Contract liabilitiesSingapore dollars thousands | 414 | 391 | PDF p. 47 |
| Lease liabilitiesSingapore dollars thousands | 829 | 228 | PDF p. 47 |
| Provision for reinstatement costsSingapore dollars thousands | 184 | 127 | PDF p. 47 |
| Deferred tax liabilitiesSingapore dollars thousands | 121 | 17 | PDF p. 47 |
| Total non-current liabilities (unlabelled in source)Singapore dollars thousands | 1,548 | 763 | PDF p. 47 |
| Current liabilities | |||
| Trade and other payablesSingapore dollars thousands | 6,010 | 2,660 | PDF p. 47 |
| Contract liabilitiesSingapore dollars thousands | 17,630 | 16,328 | PDF p. 47 |
| Lease liabilitiesSingapore dollars thousands | 570 | 686 | PDF p. 47 |
| Current tax liabilitiesSingapore dollars thousands | 3,321 | 2,364 | PDF p. 47 |
| Total current liabilities (unlabelled in source)Singapore dollars thousands | 27,531 | 22,038 | PDF p. 47 |
| Total liabilitiesSingapore dollars thousands | 29,079 | 22,801 | PDF p. 47 |
| Total equity and liabilitiesSingapore dollars thousands | 72,165 | 31,095 | PDF p. 47 |
Original report: PDF p. 47 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group / 12-month period 2025-01-01 to 2025-12-31 | 2024Group / 12-month period 2024-01-01 to 2024-12-31 | Source |
|---|---|---|---|
| income | |||
| RevenueSingapore dollars thousands | 56,486 | 43,713 | PDF p. 48 |
| Cost of salesSingapore dollars thousands | (8,363) | (6,297) | PDF p. 48 |
| Gross profitSingapore dollars thousands | 48,123 | 37,416 | PDF p. 48 |
| Other incomeSingapore dollars thousands | 200 | 115 | PDF p. 48 |
| Selling and distribution expensesSingapore dollars thousands | (10,004) | (9,492) | PDF p. 48 |
| Administrative expensesSingapore dollars thousands | (11,394) | (8,920) | PDF p. 48 |
| Research and development expensesSingapore dollars thousands | (4,187) | (3,693) | PDF p. 48 |
| Other expensesSingapore dollars thousands | (3,800) | (515) | PDF p. 48 |
| Operating profitSingapore dollars thousands | 18,938 | 14,911 | PDF p. 48 |
| Finance incomeSingapore dollars thousands | 476 | 325 | PDF p. 48 |
| Finance costsSingapore dollars thousands | (352) | (338) | PDF p. 48 |
| Net finance income/(costs)Singapore dollars thousands | 124 | (13) | PDF p. 48 |
| Profit before taxSingapore dollars thousands | 19,062 | 14,898 | PDF p. 48 |
| Tax expenseSingapore dollars thousands | (4,042) | (2,559) | PDF p. 48 |
| Profit for the yearSingapore dollars thousands | 15,020 | 12,339 | PDF p. 48 |
| Foreign operations: | |||
| – Currency translation differencesSingapore dollars thousands | 123 | (147) | PDF p. 48 |
| – Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands | − | (65) | PDF p. 48 |
| Total comprehensive income | |||
| Total comprehensive income for the year attributable to the Owners of the CompanySingapore dollars thousands | 15,143 | 12,127 | PDF p. 48 |
| Earnings per share attributable to the ordinary equity holders of the Company during the financial year | |||
| Basic earnings per share (cents)Singapore cents per share | 5.82 | 4.78 | PDF p. 48 |
| Diluted earnings per share (cents)Singapore cents per share | 5.82 | 4.78 | PDF p. 48 |
Original report: PDF p. 48 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group / 12-month period 2025-01-01 to 2025-12-31 | 2024Group / 12-month period 2024-01-01 to 2024-12-31 | Source |
|---|---|---|---|
| Cash flows from operating activities | |||
| Profit before taxSingapore dollars thousands | 19,062 | 14,898 | PDF p. 50 |
| Adjustments for: | |||
| Depreciation of property, plant and equipmentSingapore dollars thousands | 2,050 | 1,757 | PDF p. 50 |
| Amortisation of intangible assetsSingapore dollars thousands | 168 | 346 | PDF p. 50 |
| Property, plant and equipment written offSingapore dollars thousands | 64 | 105 | PDF p. 50 |
| Intangible assets written offSingapore dollars thousands | − | 10 | PDF p. 50 |
| Gain on derecognition of leaseSingapore dollars thousands | (30) | (7) | PDF p. 50 |
| Gain on liquidation of subsidiariesSingapore dollars thousands | − | (65) | PDF p. 50 |
| (Reversal of impairment loss)/Impairment loss on trade receivablesSingapore dollars thousands | (31) | 111 | PDF p. 50 |
| Bad debts written offSingapore dollars thousands | 46 | 44 | PDF p. 50 |
| Interest incomeSingapore dollars thousands | (476) | (325) | PDF p. 50 |
| Interest on lease liabilitiesSingapore dollars thousands | 189 | 194 | PDF p. 50 |
| Unwinding of discount on provision for reinstatement costsSingapore dollars thousands | 2 | 4 | PDF p. 50 |
| Operating cash before changes in working capital (unlabelled in source)Singapore dollars thousands | 21,044 | 17,072 | PDF p. 50 |
| Changes in: | |||
| InventoriesSingapore dollars thousands | (15) | 64 | PDF p. 50 |
| Trade and other receivablesSingapore dollars thousands | (7,407) | 969 | PDF p. 50 |
| Trade and other payablesSingapore dollars thousands | 3,311 | 860 | PDF p. 50 |
| Contract liabilitiesSingapore dollars thousands | 3,255 | 2,410 | PDF p. 50 |
| Cash flows from operating activities | |||
| Cash generated from operationsSingapore dollars thousands | 20,188 | 21,375 | PDF p. 50 |
| Tax paidSingapore dollars thousands | (3,360) | (3,349) | PDF p. 50 |
| Net cash generated from operating activitiesSingapore dollars thousands | 16,828 | 18,026 | PDF p. 50 |
| Cash flows from investing activities | |||
| Purchase of property, plant and equipmentSingapore dollars thousands | (962) | (381) | PDF p. 50 |
| Purchase of intangible assetsSingapore dollars thousands | (24) | (15) | PDF p. 50 |
| Capitalisation of development costsSingapore dollars thousands | (172) | − | PDF p. 50 |
| Receipt of interest incomeSingapore dollars thousands | 476 | 325 | PDF p. 50 |
| Receipt of loan repayment from shareholdersSingapore dollars thousands | 774 | − | PDF p. 50 |
| Loan to shareholdersSingapore dollars thousands | − | (3,000) | PDF p. 50 |
| Net cash generated from/(used in) investing activitiesSingapore dollars thousands | 92 | (3,071) | PDF p. 50 |
| Cash flows from financing activities | |||
| Payment of lease liabilitiesSingapore dollars thousands | (1,288) | (1,116) | PDF p. 50 |
| Dividends paidSingapore dollars thousands | (5,311) | (2,013) | PDF p. 50 |
| Interests paidSingapore dollars thousands | (189) | (194) | PDF p. 50 |
| Proceeds from issue of share capitalSingapore dollars thousands | 28,710 | − | PDF p. 50 |
| Payment of share issuance expensesSingapore dollars thousands | (1,450) | − | PDF p. 50 |
| Net cash generated from/(used in) financing activitiesSingapore dollars thousands | 20,472 | (3,323) | PDF p. 50 |
| Cash and cash equivalents reconciliation | |||
| Net increase in cash and cash equivalentsSingapore dollars thousands | 37,392 | 11,632 | PDF p. 50 |
| Cash and cash equivalents at 1 JanuarySingapore dollars thousands | 29,715 | 17,792 | PDF p. 50 |
| Effect of exchange rates fluctuations on cash and cash equivalentsSingapore dollars thousands | 177 | 291 | PDF p. 50 |
| Cash and cash equivalents at 31 DecemberSingapore dollars thousands | 67,284 | 29,715 | PDF p. 50 |
Original report: PDF p. 50 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group / 12-month period 2025-01-01 to 2025-12-31 | 2024Group / 12-month period 2024-01-01 to 2024-12-31 | Source |
|---|---|---|---|
| Group | |||
| At 1 JanuarySingapore dollars thousands | 3,542 | 2,750 | PDF p. 73 |
| Changes in financing cash flows | |||
| Payment of lease liabilitiesSingapore dollars thousands | (1,288) | (1,116) | PDF p. 73 |
| Group | |||
| Interest paidSingapore dollars thousands | (189) | (194) | PDF p. 73 |
| Total changes from financing cash flowsSingapore dollars thousands | (1,477) | (1,310) | PDF p. 73 |
| Effect of changes in foreign exchange ratesSingapore dollars thousands | (114) | 51 | PDF p. 73 |
| Liability-related other changes | |||
| New leasesSingapore dollars thousands | 2,123 | 1,936 | PDF p. 73 |
| Derecognition of lease liabilitiesSingapore dollars thousands | (270) | (79) | PDF p. 73 |
| Group | |||
| Interest expenseSingapore dollars thousands | 189 | 194 | PDF p. 73 |
| Total liability-related other changesSingapore dollars thousands | 2,042 | 2,051 | PDF p. 73 |
| Balance at 31 DecemberSingapore dollars thousands | 3,993 | 3,542 | PDF p. 73 |
Original report: PDF p. 73 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2025Group / Share capital / 12-month period 2025-01-01 to 2025-12-31 | 2025Group / Retained earnings / 12-month period 2025-01-01 to 2025-12-31 | 2025Group / Translation reserve / 12-month period 2025-01-01 to 2025-12-31 | 2025Group / Total equity / 12-month period 2025-01-01 to 2025-12-31 | Source |
|---|---|---|---|---|---|
| Changes in equity / Group / 2025 | |||||
| At 1 January 2025Singapore dollars thousands | 100 | 3,997 | (115) | 3,982 | PDF p. 49 |
| Profit for the yearSingapore dollars thousands | − | 15,020 | − | 15,020 | PDF p. 49 |
| – Currency translation differencesSingapore dollars thousands | − | − | 123 | 123 | PDF p. 49 |
| Total comprehensive income for the yearSingapore dollars thousands | – | 15,020 | 123 | 15,143 | PDF p. 49 |
| – Issuance of IPO shareSingapore dollars thousands | 28,710 | − | − | 28,710 | PDF p. 49 |
| – Share issuance expenseSingapore dollars thousands | (1,450) | − | − | (1,450) | PDF p. 49 |
| – Dividends paidSingapore dollars thousands | − | (6,499) | − | (6,499) | PDF p. 49 |
| Total transactions with ownersSingapore dollars thousands | 27,260 | (6,499) | − | 20,761 | PDF p. 49 |
| At 31 December 2025Singapore dollars thousands | 27,360 | 12,518 | 8 | 39,886 | PDF p. 49 |
Original report: PDF p. 49 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2024Group / Share capital / 12-month period 2024-01-01 to 2024-12-31 | 2024Group / Retained earnings / 12-month period 2024-01-01 to 2024-12-31 | 2024Group / Translation reserve / 12-month period 2024-01-01 to 2024-12-31 | 2024Group / Total equity / 12-month period 2024-01-01 to 2024-12-31 | Source |
|---|---|---|---|---|---|
| Changes in equity / Group / 2024 | |||||
| At 1 January 2024Singapore dollars thousands | 100 | 4,158 | 97 | 4,355 | PDF p. 49 |
| Profit for the yearSingapore dollars thousands | − | 12,339 | − | 12,339 | PDF p. 49 |
| – Currency translation differencesSingapore dollars thousands | − | − | (147) | (147) | PDF p. 49 |
| – Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands | − | − | (65) | (65) | PDF p. 49 |
| Total comprehensive income for the yearSingapore dollars thousands | − | 12,339 | (212) | 12,127 | PDF p. 49 |
| – Dividends declaredSingapore dollars thousands | − | (12,500) | − | (12,500) | PDF p. 49 |
| Total transactions with ownersSingapore dollars thousands | − | (12,500) | − | (12,500) | PDF p. 49 |
| At 31 December 2024Singapore dollars thousands | 100 | 3,997 | (115) | 3,982 | PDF p. 49 |
Original report: PDF p. 49 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2022Group / reported financial highlights / 12-month period 2022-01-01 to 2022-12-31 | 2023Group / reported financial highlights / 12-month period 2023-01-01 to 2023-12-31 | 2024Group / reported financial highlights / 12-month period 2024-01-01 to 2024-12-31 | 2025Group / reported financial highlights / 12-month period 2025-01-01 to 2025-12-31 | Source |
|---|---|---|---|---|---|
| Income Statement | |||||
| RevenueSingapore dollars thousands | 30,845 | 38,064 | 43,713 | 56,486 | PDF p. 18 |
| Gross profitSingapore dollars thousands | 26,522 | 33,125 | 37,416 | 48,123 | PDF p. 18 |
| Operating profitSingapore dollars thousands | 9,515 | 13,233 | 14,911 | 18,938 | PDF p. 18 |
| EBITDASingapore dollars thousands | 10,718 | 15,137 | 17,014 | 21,156 | PDF p. 18 |
| Profit before taxSingapore dollars thousands | 9,370 | 13,005 | 14,898 | 19,062 | PDF p. 18 |
| Profit attributable to owners of the companySingapore dollars thousands | 7,185 | 10,487 | 12,339 | 15,020 | PDF p. 18 |
| Balance Sheet | |||||
| Total assetsSingapore dollars thousands | 28,959 | 36,088 | 39,668 | 83,932 | PDF p. 18 |
| Contract liabilitiesSingapore dollars thousands | 20,440 | 22,750 | 25,565 | 28,967 | PDF p. 18 |
| Total liabilitiesSingapore dollars thousands | 28,157 | 31,733 | 35,686 | 44,046 | PDF p. 18 |
| Equity attributable to owners of the companySingapore dollars thousands | 802 | 4,355 | 3,982 | 39,886 | PDF p. 18 |
| Cash Flow Statement | |||||
| Net cash generated from operating activitiesSingapore dollars thousands | 10,686 | 14,550 | 18,026 | 16,828 | PDF p. 18 |
| Net cash (used) / generated from investing activitiesSingapore dollars thousands | (10,978) | (7,566) | (3,071) | 92 | PDF p. 18 |
| Net cash (used) / generated from financing activitiesSingapore dollars thousands | (7,754) | (1,068) | (3,323) | 20,472 | PDF p. 18 |
| Net (decrease) / increase in cash and cash equivalentsSingapore dollars thousands | (8,046) | 5,916 | 11,632 | 37,392 | PDF p. 18 |
| Cash and cash equivalents at end of yearSingapore dollars thousands | 11,758 | 17,792 | 29,715 | 67,284 | PDF p. 18 |
| Financial statistics | |||||
| Gross profit margin (%)Percent | 86.0 | 87.0 | 85.6 | 85.2 | PDF p. 18 |
| EBITDA margin (%)Percent | 34.7 | 39.8 | 38.9 | 37.5 | PDF p. 18 |
| Net profit margin (%)Percent | 23.3 | 27.6 | 28.2 | 26.6 | PDF p. 18 |
| Earnings per share (cents)Singapore cents per share | 2.78 | 4.06 | 4.78 | 5.82 | PDF p. 18 |
| Dividend per share (cents)Singapore cents per share | - | - | - | 3.50 | PDF p. 18 |
Original report: PDF p. 18 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2023Group / audited actual IPO Appendix A / as at 2023-12-31 | 2022Group / audited actual IPO Appendix A / as at 2022-12-31 | Source |
|---|---|---|---|
| Non-current assets | |||
| Property, plant and equipmentSingapore dollars thousands | 3,805 | 3,544 | PDF p. 220 |
| Intangible assetsSingapore dollars thousands | 554 | 586 | PDF p. 220 |
| Deferred tax assetsSingapore dollars thousands | 1,110 | 834 | PDF p. 220 |
| Total non-current assets (unlabelled in source)Singapore dollars thousands | 5,469 | 4,964 | PDF p. 220 |
| Current assets | |||
| InventoriesSingapore dollars thousands | 143 | 84 | PDF p. 220 |
| Trade and other receivablesSingapore dollars thousands | 12,684 | 12,153 | PDF p. 220 |
| Cash and cash equivalentsSingapore dollars thousands | 17,792 | 11,758 | PDF p. 220 |
| Total current assets (unlabelled in source)Singapore dollars thousands | 30,619 | 23,995 | PDF p. 220 |
| Total assetsSingapore dollars thousands | 36,088 | 28,959 | PDF p. 220 |
| Equity | |||
| Share capitalSingapore dollars thousands | 100 | 100 | PDF p. 220 |
| Retained earningsSingapore dollars thousands | 4,158 | 671 | PDF p. 220 |
| Translation reserveSingapore dollars thousands | 97 | 31 | PDF p. 220 |
| Equity attributable to the owners of the CompanySingapore dollars thousands | 4,355 | 802 | PDF p. 220 |
| Non-current liabilities | |||
| Contract liabilitiesSingapore dollars thousands | 1,077 | 599 | PDF p. 220 |
| Lease liabilitiesSingapore dollars thousands | 1,688 | 1,965 | PDF p. 220 |
| Provision for reinstatement costsSingapore dollars thousands | 116 | 111 | PDF p. 220 |
| Deferred tax liabilitiesSingapore dollars thousands | 27 | 27 | PDF p. 220 |
| Total non-current liabilities (unlabelled in source)Singapore dollars thousands | 2,908 | 2,702 | PDF p. 220 |
| Current liabilities | |||
| Trade and other payablesSingapore dollars thousands | 3,380 | 2,907 | PDF p. 220 |
| Contract liabilitiesSingapore dollars thousands | 21,673 | 19,841 | PDF p. 220 |
| Lease liabilitiesSingapore dollars thousands | 1,062 | 879 | PDF p. 220 |
| Current tax liabilitiesSingapore dollars thousands | 2,710 | 1,828 | PDF p. 220 |
| Total current liabilities (unlabelled in source)Singapore dollars thousands | 28,825 | 25,455 | PDF p. 220 |
| Total liabilitiesSingapore dollars thousands | 31,733 | 28,157 | PDF p. 220 |
| Total equity and liabilitiesSingapore dollars thousands | 36,088 | 28,959 | PDF p. 220 |
Original report: PDF p. 220 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2023Group / audited actual IPO Appendix A / 12-month period 2023-01-01 to 2023-12-31 | 2022Group / audited actual IPO Appendix A / 12-month period 2022-01-01 to 2022-12-31 | Source |
|---|---|---|---|
| income | |||
| RevenueSingapore dollars thousands | 38,064 | 30,845 | PDF p. 221 |
| Cost of salesSingapore dollars thousands | (4,939) | (4,323) | PDF p. 221 |
| Gross profitSingapore dollars thousands | 33,125 | 26,522 | PDF p. 221 |
| Other incomeSingapore dollars thousands | 160 | 368 | PDF p. 221 |
| Selling and distribution expensesSingapore dollars thousands | (8,056) | (7,152) | PDF p. 221 |
| Administrative expensesSingapore dollars thousands | (8,419) | (6,337) | PDF p. 221 |
| Research and development expensesSingapore dollars thousands | (2,860) | (2,743) | PDF p. 221 |
| Other expensesSingapore dollars thousands | (717) | (1,143) | PDF p. 221 |
| Operating profitSingapore dollars thousands | 13,233 | 9,515 | PDF p. 221 |
| Finance incomeSingapore dollars thousands | 17 | 4 | PDF p. 221 |
| Finance costsSingapore dollars thousands | (245) | (149) | PDF p. 221 |
| Net finance costsSingapore dollars thousands | (228) | (145) | PDF p. 221 |
| Profit before taxSingapore dollars thousands | 13,005 | 9,370 | PDF p. 221 |
| Tax expenseSingapore dollars thousands | (2,518) | (2,185) | PDF p. 221 |
| Profit for the yearSingapore dollars thousands | 10,487 | 7,185 | PDF p. 221 |
| Foreign operations: | |||
| – Currency translation differencesSingapore dollars thousands | 66 | 34 | PDF p. 221 |
| – Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands | − | − | PDF p. 221 |
| Total comprehensive income | |||
| Total comprehensive income for the year attributable to the Owners of the CompanySingapore dollars thousands | 10,553 | 7,219 | PDF p. 221 |
| Earnings per share attributable to the ordinary equity holders of the Company during the financial year | |||
| Basic earnings per share (cents)Singapore cents per share | 4.66 | 3.19 | PDF p. 221 |
| Diluted earnings per share (cents)Singapore cents per share | 4.66 | 3.19 | PDF p. 221 |
Original report: PDF p. 221 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2023Group / audited actual IPO Appendix A / 12-month period 2023-01-01 to 2023-12-31 | 2022Group / audited actual IPO Appendix A / 12-month period 2022-01-01 to 2022-12-31 | Source |
|---|---|---|---|
| Cash flows from operating activities | |||
| Profit before taxSingapore dollars thousands | 13,005 | 9,370 | PDF p. 224 |
| Adjustments for: | |||
| Depreciation of property, plant and equipmentSingapore dollars thousands | 1,612 | 971 | PDF p. 224 |
| Amortisation of intangible assetsSingapore dollars thousands | 291 | 232 | PDF p. 224 |
| Loss on property, plant and equipment written offSingapore dollars thousands | 69 | 57 | PDF p. 224 |
| Loss on intangible assets written offSingapore dollars thousands | − | − | PDF p. 224 |
| Gain on derecognition of leaseSingapore dollars thousands | − | (22) | PDF p. 224 |
| Gain on liquidation of subsidiariesSingapore dollars thousands | − | − | PDF p. 224 |
| Impairment loss/(Reversal of impairment loss) on trade receivablesSingapore dollars thousands | (32) | 161 | PDF p. 224 |
| Bad debts written offSingapore dollars thousands | − | 78 | PDF p. 224 |
| Interest incomeSingapore dollars thousands | (17) | (4) | PDF p. 224 |
| Interest on lease liabilitiesSingapore dollars thousands | 135 | 48 | PDF p. 224 |
| Unwinding of discount on provision for reinstatement costsSingapore dollars thousands | 5 | − | PDF p. 224 |
| Operating cash before changes in working capital (unlabelled in source)Singapore dollars thousands | 15,068 | 10,891 | PDF p. 224 |
| Changes in: | |||
| InventoriesSingapore dollars thousands | (58) | (4) | PDF p. 224 |
| Trade and other receivablesSingapore dollars thousands | (926) | (909) | PDF p. 224 |
| Trade and other payablesSingapore dollars thousands | 123 | 674 | PDF p. 224 |
| Contract liabilitiesSingapore dollars thousands | 2,310 | 2,530 | PDF p. 224 |
| Cash flows from operating activities | |||
| Cash generated from operationsSingapore dollars thousands | 16,517 | 13,182 | PDF p. 224 |
| Tax paidSingapore dollars thousands | (1,967) | (2,496) | PDF p. 224 |
| Net cash generated from operating activitiesSingapore dollars thousands | 14,550 | 10,686 | PDF p. 224 |
| Cash flows from investing activities | |||
| Purchase of property, plant and equipmentSingapore dollars thousands | (1,099) | (455) | PDF p. 224 |
| Purchase of intangible assetsSingapore dollars thousands | (13) | (10) | PDF p. 224 |
| Capitalisation of development costsSingapore dollars thousands | (247) | (292) | PDF p. 224 |
| Receipt of interest incomeSingapore dollars thousands | 17 | 4 | PDF p. 224 |
| Loans to shareholdersSingapore dollars thousands | (6,224) | (10,225) | PDF p. 224 |
| Net cash used in investing activitiesSingapore dollars thousands | (7,566) | (10,978) | PDF p. 224 |
| Cash flows from financing activities | |||
| Payment of lease liabilitiesSingapore dollars thousands | (933) | (606) | PDF p. 224 |
| Interest paidSingapore dollars thousands | (135) | (48) | PDF p. 224 |
| Dividends paidSingapore dollars thousands | − | (7,100) | PDF p. 224 |
| Net cash used in financing activitiesSingapore dollars thousands | (1,068) | (7,754) | PDF p. 224 |
| Cash and cash equivalents reconciliation | |||
| Net increase/(decrease) in cash and cash equivalentsSingapore dollars thousands | 5,916 | (8,046) | PDF p. 224 |
| Cash and cash equivalents at 1 JanuarySingapore dollars thousands | 11,758 | 19,688 | PDF p. 224 |
| Effect of exchange rates fluctuations on cash and cash equivalentsSingapore dollars thousands | 118 | 116 | PDF p. 224 |
| Cash and cash equivalents at 31 DecemberSingapore dollars thousands | 17,792 | 11,758 | PDF p. 224 |
Original report: PDF p. 224 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2023Group / audited actual IPO Appendix A / 12-month period 2023-01-01 to 2023-12-31 | 2022Group / audited actual IPO Appendix A / 12-month period 2022-01-01 to 2022-12-31 | Source |
|---|---|---|---|
| finance | |||
| At 1 JanuarySingapore dollars thousands | 2,844 | 1,086 | PDF p. 248 |
| Changes in financing cash flows | |||
| Payment of lease liabilitiesSingapore dollars thousands | (933) | (606) | PDF p. 248 |
| finance | |||
| Interest paidSingapore dollars thousands | (135) | (48) | PDF p. 248 |
| Total changes from financing cash flowsSingapore dollars thousands | (1,068) | (654) | PDF p. 248 |
| Effect of changes in foreign exchange ratesSingapore dollars thousands | (91) | (47) | PDF p. 248 |
| Liability-related other changes | |||
| New leasesSingapore dollars thousands | 930 | 2,595 | PDF p. 248 |
| finance | |||
| Modification of lease contractsSingapore dollars thousands | – | 79 | PDF p. 248 |
| Liability-related other changes | |||
| Derecognition of lease liabilitiesSingapore dollars thousands | – | (263) | PDF p. 248 |
| finance | |||
| Interest expenseSingapore dollars thousands | 135 | 48 | PDF p. 248 |
| Total liability-related other changesSingapore dollars thousands | 1,065 | 2,459 | PDF p. 248 |
| Balance at 31 DecemberSingapore dollars thousands | 2,750 | 2,844 | PDF p. 248 |
Original report: PDF p. 248 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2023Group / Share capital / 12-month period 2023-01-01 to 2023-12-31 | 2023Group / Retained earnings / 12-month period 2023-01-01 to 2023-12-31 | 2023Group / Translation reserve / 12-month period 2023-01-01 to 2023-12-31 | 2023Group / Total equity / 12-month period 2023-01-01 to 2023-12-31 | Source |
|---|---|---|---|---|---|
| Changes in equity / Group / 2023 | |||||
| At 1 January 2023Singapore dollars thousands | 100 | 671 | 31 | 802 | PDF p. 222 |
| Profit for the yearSingapore dollars thousands | − | 10,487 | − | 10,487 | PDF p. 222 |
| – Currency translation differencesSingapore dollars thousands | − | − | 66 | 66 | PDF p. 222 |
| Total comprehensive income for the yearSingapore dollars thousands | − | 10,487 | 66 | 10,553 | PDF p. 222 |
| Dividends declaredSingapore dollars thousands | − | (7,000) | − | (7,000) | PDF p. 222 |
| Total transactions with ownersSingapore dollars thousands | − | (7,000) | − | (7,000) | PDF p. 222 |
| At 31 December 2023Singapore dollars thousands | 100 | 4,158 | 97 | 4,355 | PDF p. 222 |
Original report: PDF p. 222 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2022Group / Share capital / 12-month period 2022-01-01 to 2022-12-31 | 2022Group / Retained earnings / 12-month period 2022-01-01 to 2022-12-31 | 2022Group / Translation reserve / 12-month period 2022-01-01 to 2022-12-31 | 2022Group / Total equity / 12-month period 2022-01-01 to 2022-12-31 | Source |
|---|---|---|---|---|---|
| Changes in equity / Group / 2022 | |||||
| At 1 January 2022Singapore dollars thousands | 100 | 586 | (3) | 683 | PDF p. 222 |
| Profit for the yearSingapore dollars thousands | – | 7,185 | – | 7,185 | PDF p. 222 |
| – Currency translation differencesSingapore dollars thousands | – | – | 34 | 34 | PDF p. 222 |
| Total comprehensive income for the yearSingapore dollars thousands | – | 7,185 | 34 | 7,219 | PDF p. 222 |
| Dividends declaredSingapore dollars thousands | – | (7,100) | – | (7,100) | PDF p. 222 |
| Total transactions with ownersSingapore dollars thousands | – | (7,100) | – | (7,100) | PDF p. 222 |
| At 31 December 2022Singapore dollars thousands | 100 | 671 | 31 | 802 | PDF p. 222 |
Original report: PDF p. 222 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Units appear below each metric. Scroll to compare years
| Metric / unit | 2024Group / original IPO actual / EPS on pre-invitation 225 million shares / 12-month period 2024-01-01 to 2024-12-31 | Source |
|---|---|---|
| income | ||
| RevenueSingapore dollars thousands | 43,713 | PDF p. 221 |
| Cost of salesSingapore dollars thousands | (6,297) | PDF p. 221 |
| Gross profitSingapore dollars thousands | 37,416 | PDF p. 221 |
| Other incomeSingapore dollars thousands | 115 | PDF p. 221 |
| Selling and distribution expensesSingapore dollars thousands | (9,492) | PDF p. 221 |
| Administrative expensesSingapore dollars thousands | (8,920) | PDF p. 221 |
| Research and development expensesSingapore dollars thousands | (3,693) | PDF p. 221 |
| Other expensesSingapore dollars thousands | (515) | PDF p. 221 |
| Operating profitSingapore dollars thousands | 14,911 | PDF p. 221 |
| Finance incomeSingapore dollars thousands | 325 | PDF p. 221 |
| Finance costsSingapore dollars thousands | (338) | PDF p. 221 |
| Net finance costsSingapore dollars thousands | (13) | PDF p. 221 |
| Profit before taxSingapore dollars thousands | 14,898 | PDF p. 221 |
| Tax expenseSingapore dollars thousands | (2,559) | PDF p. 221 |
| Profit for the yearSingapore dollars thousands | 12,339 | PDF p. 221 |
| Foreign operations: | ||
| – Currency translation differencesSingapore dollars thousands | (147) | PDF p. 221 |
| – Currency translation differences reclassified to profit or loss on liquidation of subsidiariesSingapore dollars thousands | (65) | PDF p. 221 |
| Total comprehensive income | ||
| Total comprehensive income for the year attributable to the Owners of the CompanySingapore dollars thousands | 12,127 | PDF p. 221 |
| Earnings per share attributable to the ordinary equity holders of the Company during the financial year | ||
| Basic earnings per share (cents)Singapore cents per share | 5.48 | PDF p. 221 |
| Diluted earnings per share (cents)Singapore cents per share | 5.48 | PDF p. 221 |
Original report: PDF p. 221 ↗
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
Where the money comes from
| Item / unit | 2025Group | 2024Group | Source |
|---|---|---|---|
| Revenues | |||
| Total revenue for reportable segments$’000 | 57,016 | 44,179 | PDF p. 87 |
| Revenue for other segments$’000 | 7,906 | 6,386 | PDF p. 87 |
| Elimination of inter-segment revenue$’000 | (8,436) | (6,852) | PDF p. 87 |
| Consolidated revenue$’000 | 56,486 | 43,713 | PDF p. 87 |
| Profit or loss before tax | |||
| Total profit before tax for reportable segments$’000 | 18,847 | 14,955 | PDF p. 87 |
| Profit/(Loss) before tax for other segments$’000 | 215 | (391) | PDF p. 87 |
| Elimination of inter-segment profits$’000 | – | 334 | PDF p. 87 |
| Consolidated profit before tax$’000 | 19,062 | 14,898 | PDF p. 87 |
| Assets | |||
| Total assets^ for reportable segments$’000 | 77,844 | 32,508 | PDF p. 87 |
| Total assets^ for other segments$’000 | 4,038 | 5,562 | PDF p. 87 |
| Deferred tax assets$’000 | 2,050 | 1,598 | PDF p. 87 |
| Consolidated total assets$’000 | 83,932 | 39,668 | PDF p. 87 |
| Liabilities | |||
| Total liabilities* for reportable segments$’000 | 36,295 | 29,123 | PDF p. 87 |
| Total liabilities* for other segments$’000 | 4,292 | 4,194 | PDF p. 87 |
| Deferred tax liabilities$’000 | 121 | 17 | PDF p. 87 |
| Current tax liabilities$’000 | 3,338 | 2,352 | PDF p. 87 |
| Consolidated total liabilities$’000 | 44,046 | 35,686 | PDF p. 87 |
^ Exclude deferred tax assets
* Exclude deferred tax liabilities and current tax liabilities
The unlabelled subtotal 19,062 / 14,564 printed between 'Profit/(Loss) before tax for other segments' and 'Elimination of inter-segment profits' is not extracted as a row.
| Item / unit | 2025Singapore | 2025Malaysia | 2025Others | 2025Total | 2024Singapore | 2024Malaysia | 2024Others | 2024Total | Source |
|---|---|---|---|---|---|---|---|---|---|
| Information about reportable segments | |||||||||
| External revenue$’000 | 42,659 | 10,308 | 3,519 | 56,486 | 32,831 | 8,240 | 2,642 | 43,713 | PDF p. 85PDF p. 86 |
| Inter-segment revenue$’000 | 4,049 | – | 4,387 | 8,436 | 3,097 | 11 | 3,744 | 6,852 | PDF p. 85PDF p. 86 |
| Finance income$’000 | 461 | 15 | – | 476 | 314 | 11 | – | 325 | PDF p. 85PDF p. 86 |
| Finance costs$’000 | (174) | (80) | (98) | (352) | (181) | (64) | (93) | (338) | PDF p. 85PDF p. 86 |
| Government grants income$’000 | 29 | – | – | 29 | 34 | – | – | 34 | PDF p. 85PDF p. 86 |
| Depreciation of property, plant and equipment$’000 | (1,059) | (601) | (390) | (2,050) | (973) | (453) | (331) | (1,757) | PDF p. 85PDF p. 86 |
| Amortisation of intangible assets$’000 | (146) | – | (22) | (168) | (334) | – | (12) | (346) | PDF p. 85PDF p. 86 |
| Segment profit/(loss) before tax$’000 | 18,341 | 3,333 | (2,612) | 19,062 | 15,471 | 2,423 | (2,996) | 14,898 | PDF p. 85PDF p. 86 |
| Other material items of income and expense and non-cash items | |||||||||
| – Advertising expenses$’000 | (2,724) | (600) | (536) | (3,860) | (2,323) | (880) | (518) | (3,721) | PDF p. 85PDF p. 86 |
| – Hosting expenses$’000 | (714) | (321) | (81) | (1,116) | (610) | (336) | (88) | (1,034) | PDF p. 85PDF p. 86 |
| – Employee benefits expenses$’000 | (13,884) | (4,651) | (4,169) | (22,704) | (11,103) | (3,705) | (3,784) | (18,592) | PDF p. 85PDF p. 86 |
| Information about reportable segments | |||||||||
| Reportable segment assets^$’000 | 64,844 | 13,000 | 4,038 | 81,882 | 23,513 | 8,995 | 5,562 | 38,070 | PDF p. 85PDF p. 86 |
| Capital expenditure | |||||||||
| – Property, plant and equipment#$’000 | (807) | (154) | (1) | (962) | (47) | (209) | (125) | (381) | PDF p. 85PDF p. 86 |
| – Intangible assets$’000 | – | – | (24) | (24) | – | – | (15) | (15) | PDF p. 85PDF p. 86 |
| Information about reportable segments | |||||||||
| Reportable segment liabilities*$’000 | 25,724 | 10,571 | 4,292 | 40,587 | 20,532 | 8,591 | 4,194 | 33,317 | PDF p. 85PDF p. 86 |
^ Exclude deferred tax assets; * Exclude deferred tax liabilities and current tax liabilities; # Exclude right-of-use assets (footnotes printed on page 86). Group has two reportable geographical segments (Singapore and Malaysia); Others = Hong Kong and India HRMS/accounting software sales.
^ Exclude deferred tax assets
* Exclude deferred tax liabilities and current tax liabilities
# Exclude right-of-use assets
Debt
| Item / unit | 2025Group | 2024Group | 2025Company | 2024Company | Source |
|---|---|---|---|---|---|
| Group 31 December 2025: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years | |||||
| Lease liabilities (Group 2025)$'000 | 3,993 | (4,537) | (1,388) | (3,149) | PDF p. 82 |
| Group 31 December 2024: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years | |||||
| Lease liabilities (Group 2024)$'000 | 3,542 | (4,125) | (1,313) | (2,812) | PDF p. 82 |
| Company 31 December 2025: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years | |||||
| Lease liabilities (Company 2025)$'000 | 1,399 | (1,566) | (655) | (911) | PDF p. 82 |
| Company 31 December 2024: Carrying amount; Contractual cash flows; Within 1 year; Between 2 to 5 years | |||||
| Lease liabilities (Company 2024)$'000 | 914 | (1,000) | (755) | (245) | PDF p. 82 |
Amounts are gross and undiscounted, include contractual interest payments and exclude the impact of netting agreements. Each row's four values map to Carrying amount, Contractual cash flows, Within 1 year, Between 2 to 5 years. Column year/scope of table applies by row label.
| Item / unit | 2025Group | 2024Group | 2025Company | 2024Company | Source |
|---|---|---|---|---|---|
| Lease liabilities | |||||
| Non-current$'000 | 2,808 | 2,422 | 829 | 228 | PDF p. 72 |
| Current$'000 | 1,185 | 1,120 | 570 | 686 | PDF p. 72 |
The report discloses no bank borrowings (page 8 refers to zero borrowings); only lease liabilities are reported as debt. The unlabelled total row prints 3,993 3,542 1,399 914.
Payout
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dividend policy | The Company does not have a fixed dividend policy. However, the Board intends to recommend and distribute at least 50% of its adjusted net profit after tax as dividends to shareholders for FY2025 and FY2026. Any dividend payouts will be communicated to shareholders via announcements on SGXNET when the Company releases its financial results. | Company | PDF p. 40 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Final dividend of 1.95 cent per ordinary share (2024: Nil) | 1.95 cents per share | Company, FY2025 final dividend proposed, exempt (one-tier) | PDF p. 72 |
| Second interim dividend of 1.55 cent (2024: $50) per ordinary share | 1.55 cents per share | Company, FY2025 second interim dividend declared, exempt (one-tier) | PDF p. 71 |
| First interim dividend of $25 (2024: $75) per ordinary share | $25 | Company, FY2025 first interim dividend declared, exempt (one-tier) | PDF p. 71 |
| Declared by the Company to owners of the Company | 6,499 $'000 | Company and Group, dividends declared FY2025 (2024: 12,500) | PDF p. 71 |
| TOTAL DIVIDEND | 3.50 cents per ordinary share | FY2025 total (interim 1.55 paid + final 1.95 proposed) | PDF p. 9 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dividend and Outlook | approximately 60% of net profit after tax and 50% of adjusted net profit after tax | FY2025 | PDF p. 9 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Auditor’s report
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Audit firm | KPMG LLP | Group, FY2025 | PDF p. 46 |
| Engagement partner | Sarina Lee | Group, FY2025 | PDF p. 46 |
| Opinion | In our opinion, the accompanying consolidated financial statements of the Group and the statement of financial position of the Company are properly drawn up | Group and Company, as at 31 December 2025 | PDF p. 44 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Revenue Recognition | Revenue Recognition | Group, FY2025 | PDF p. 44 |
| Revenue Recognition – description | The calculation of subscription revenue and the related contract liabilities involve manual computations. | Group, FY2025 | PDF p. 44 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Group and parent company or bank figures are labelled separately. Parentheses indicate negative amounts; a dash and NA retain the report’s notation.
Comparative figures follow Annual Report 2025, including retrospective adjustments. Adjusted and reported earnings may have different definitions; refer to each statement’s notes.
Four available complete audited Group annual periods are FY2022–FY2025, each 1 January to 31 December. The FY2025 annual report is the first published annual report following the 4 July 2025 SGX listing. FY2022–FY2024 actual consolidated statements are in Appendix A of the official SGX final prospectus dated 27 June 2025. Appendix B unaudited pro forma FY2024 is not substituted for those actual statements. A full FY2021 audited annual statement source has not been established; the opening equity balance at 1 January 2022 is not a complete FY2021 statement set.
All monetary statement amounts are Singapore dollars thousands; basic and diluted earnings per share are Singapore cents. The latest annual report discloses financial position for Group and Company, and Group consolidated combined profit or loss and other comprehensive income, changes in equity and cash flows. Separate Company income, OCI, equity and cash-flow primary statements are not disclosed in the inspected annual report. The historical Appendix A statements are Group consolidated.
The FY2025 audit opinion is unmodified, KPMG LLP, partner Sarina Lee, dated 27 March 2026. Revenue recognition is a key audit matter; the annual auditor report discusses subscription revenue of 39,102 thousand, 69% of revenue. The historical FY2022–FY2024 Appendix A audit opinion is unmodified, KPMG LLP, Sarina Lee, dated 20 June 2025 except for Note 21 subsequent event, for which the date is 27 June 2025. Its report restricts use to inclusion in the listing prospectus.
The current annual report and historical IPO actual statements agree on FY2024 monetary values; original captions, nil rows and cash-flow row order can differ. The original IPO FY2024 income and EPS statement is retained because its EPS denominator differs from the annual comparative.
The FY2025 annual report Note 20 explicitly computes both FY2025 and FY2024 comparative basic EPS using 258,000 thousand shares, assuming that the share split and issuance of new shares had been effected for comparative purposes. EPS is 5.82 cents and 4.78 cents from profits of 15,020 and 12,339 thousand. This is the stated assumed share-capital basis; it is not labelled as an actual time-weighted share count.
The IPO Appendix A Note 19 uses the pre-invitation share capital of 225,000 thousand shares for FY2024, FY2023 and FY2022. Original EPS is respectively 5.48, 4.66 and 3.19 cents on profits of 12,339, 10,487 and 7,185 thousand. Basic and diluted EPS are equal because there are no potential dilutive ordinary shares. The annual-report financial highlights separately disclose FY2022–FY2025 EPS of 2.78, 4.06, 4.78 and 5.82 cents based on 258,000,000 shares. That reported summary is retained separately from the original audited IPO EPS basis.
On 30 May 2025 each of the original 100,000 shares was subdivided into 2,250 shares, producing 225,000,000 shares without changing the S$100,000 share capital. On 4 July 2025 the Company issued 33,000,000 new shares at S$0.87, raising 28,710 thousand gross. Equity issuance expenses were 1,450 thousand; the separately expensed listing costs were 2,930 thousand. Closing ordinary shares were 258,000,000 and share capital 27,360 thousand.
FY2025 Group dividends of 6,499 thousand include a noncash offset of 1,188 thousand against shareholder loans; cash dividends were 5,311 thousand. FY2024 declared dividends of 12,500 less loan offset 10,837 plus the prior-year dividend payable 350 reconcile to cash dividends 2,013. The 774 thousand cash receipt from shareholder loan repayments is separately an investing cash flow.
FY2025 PPE acquisition of 3,140 thousand includes noncash right-of-use assets of 2,178; cash PPE purchase is 962. FY2024 acquisition of 2,324 includes right-of-use assets of 1,943; cash PPE purchase is 381. Right-of-use assets are within PPE and are not an extra asset to add to the balance sheet.
The lease liability reconciliation separates principal payments, interest paid, exchange movements, new leases, derecognition and interest expense. For FY2025, opening 3,542 less total cash outflow 1,477 less FX 114 plus other changes 2,042 equals closing 3,993, which is 2,808 noncurrent plus 1,185 current. FY2024 closing lease liabilities are 3,542, FY2023 2,750 and FY2022 2,844.
New right-of-use assets include reinstatement costs: FY2025 55 thousand and FY2024 7 thousand. Thus FY2025 ROU additions 2,178 differ from new lease liabilities 2,123, and FY2024 ROU additions 1,943 differ from new lease liabilities 1,936. Historical FY2022 ROU additions 2,706 include reinstatement costs 111 versus new lease liabilities 2,595.
Equity rows showing total comprehensive income and total owner transactions are subtotals, rather than additional movements to sum again. Currency translation reclassification on liquidation in FY2024 is retained alongside currency translation differences. No non-controlling interest is invented for wholly owned subsidiaries.
IPO Appendix A Note 21 says the April 2025 dividend of 2,500 thousand was fully settled through a loan offset of 1,188 and cash repayment 774; those two printed amounts sum to 1,962. The annual report separately shows the 774 shareholder loan repayment as an investing cash receipt and reconciles full-year dividends using 6,499 less 1,188 equals 5,311 cash. No missing payment or balancing item is invented. The IPO subsequent-event split wording refers to subdivision into 225,000,000 shares; the annual Note 10 explicitly gives the actual 1:2,250 split from 100,000 to 225,000,000 shares.
Printed dashes are retained as printed. Unlabelled original subtotals are explicitly marked as unlabelled in source. Source links identify the original document and physical page for each row.
FY2023 reported EBITDA in the annual financial highlights is 15,137 thousand, while original operating profit 13,233 plus depreciation 1,612 and amortisation 291 equals 15,136. The printed one-thousand discrepancy is preserved without inventing a rounding or other adjustment.
The complete reported four-year financial highlights include unadjusted EBITDA, three margins, EPS on 258 million shares and dividend per share. FY2025 headline adjusted PAT and adjusted EBITDA on the separate highlights page exclude approximately 2.9 million listing and 0.1 million Malaysia relocation expenses; they are not substituted for statutory profit or the unadjusted EBITDA summary. The summary FY2025 DPS 3.50 cents comprises interim 1.55 cents and final 1.95 cents proposed at the annual-report date; final dividend approval is established by the 24 April 2026 AGM results. Earlier DPS summary dashes are retained despite separate pre-IPO absolute dividend disclosures in the statutory notes.
These tables show the available extracted figures. The original annual report contains the full statements, notes and definitions.